Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025)

Siga Technologies (SIGA) posted Total Non-Current Liabilities of $18.0 million for Q4 2025, down 27.57% on a QoQ basis from $24.8 million in Q3 2025, and down 28.97% year-over-year from $25.3 million in Q4 2024.

Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Siga Technologies' Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $18.0 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 28.97% year-over-year to $18.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.0 million (down 28.97% YoY) and the FY2025 annual result came in at $18.0 million, down 28.97% from the prior year.
  • Total Non-Current Liabilities was $18.0 million for Q4 2025 at Siga Technologies, down from $24.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $74.8 million in Q1 2024 and bottomed at $13.2 million in Q1 2021.
  • A 5-year average of $26.4 million and a median of $22.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 304.9% — and 2025, when it plunged 62.84%.
  • Siga Technologies' Total Non-Current Liabilities stood at $33.9 million in 2021, then tumbled by 36.51% to $21.5 million in 2022, then jumped by 151.5% to $54.1 million in 2023, then plunged by 53.19% to $25.3 million in 2024, then fell by 28.97% to $18.0 million in 2025.
  • Business Quant data shows SIGA's Total Non-Current Liabilities at $18.0 million in Q4 2025, $24.8 million in Q3 2025, and $22.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Siga Technologies 225.56 Mn 70.59 Mn - 17.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.99 Mn
Sep 30, 2025 24.84 Mn
Jun 30, 2025 22.72 Mn
Mar 31, 2025 27.80 Mn
Dec 31, 2024 25.33 Mn
Sep 30, 2024 22.30 Mn
Jun 30, 2024 21.38 Mn
Mar 31, 2024 74.81 Mn
Dec 31, 2023 54.12 Mn
Sep 30, 2023 30.74 Mn
Jun 30, 2023 18.99 Mn
Mar 31, 2023 18.48 Mn
Dec 31, 2022 21.52 Mn
Sep 30, 2022 31.09 Mn
Jun 30, 2022 16.69 Mn
Mar 31, 2022 13.41 Mn
Dec 31, 2021 33.89 Mn
Sep 30, 2021 25.29 Mn
Jun 30, 2021 13.25 Mn
Mar 31, 2021 13.23 Mn